English
简体中文
Total: £ 56.28
Published Date: 2024-10-17 | Pages: 97 | Tables: 206 | Pharma & Healthcare
Human varicella-zoster immune globulin is a solution of antibodies used for post exposure prophylaxis of varicella infections in high risk populations, as well as to reduce the severity of infections.
The global market for Human Varicella-Zoster Immunoglobulin was estimated to be worth US$ 159 million in 2023 and is forecast to a readjusted size of US$ 201.1 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030
Herpes zoster is an acute herpetic viral skin disease caused by the varicella-zoster virus that involves the nerves and skin. Infected individuals treated with human water were less likely to develop severe varicella-zoster virus than those not treated with it.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Varicella-Zoster Immunoglobulin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human Varicella-Zoster Immunoglobulin by region & country, by Type, and by Application.
The Human Varicella-Zoster Immunoglobulin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Varicella-Zoster Immunoglobulin.
Market Segmentation
By Company
Bio Products Laboratory
MassBiologics
Saol Therapeutics
Aptevo Biotherapeutics Llc
Ki Biopharma Llc
Cangene Biopharma
Kamada
Salmedon
Segment by Type:
Freeze-dried Powder
Injection
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Human Varicella-Zoster Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Human Varicella-Zoster Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Human Varicella-Zoster Immunoglobulin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Human Varicella-Zoster Immunoglobulin Product Introduction
1.2 Global Human Varicella-Zoster Immunoglobulin Market Size Forecast
1.2.1 Global Human Varicella-Zoster Immunoglobulin Sales Value (2019-2030)
1.2.2 Global Human Varicella-Zoster Immunoglobulin Sales Volume (2019-2030)
1.2.3 Global Human Varicella-Zoster Immunoglobulin Sales Price (2019-2030)
1.3 Human Varicella-Zoster Immunoglobulin Market Trends & Drivers
1.3.1 Human Varicella-Zoster Immunoglobulin Industry Trends
1.3.2 Human Varicella-Zoster Immunoglobulin Market Drivers & Opportunity
1.3.3 Human Varicella-Zoster Immunoglobulin Market Challenges
1.3.4 Human Varicella-Zoster Immunoglobulin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Varicella-Zoster Immunoglobulin Players Revenue Ranking (2023)
2.2 Global Human Varicella-Zoster Immunoglobulin Revenue by Company (2019-2024)
2.3 Global Human Varicella-Zoster Immunoglobulin Players Sales Volume Ranking (2023)
2.4 Global Human Varicella-Zoster Immunoglobulin Sales Volume by Company Players (2019-2024)
2.5 Global Human Varicella-Zoster Immunoglobulin Average Price by Company (2019-2024)
2.6 Key Manufacturers Human Varicella-Zoster Immunoglobulin Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Human Varicella-Zoster Immunoglobulin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Human Varicella-Zoster Immunoglobulin
2.9 Human Varicella-Zoster Immunoglobulin Market Competitive Analysis
2.9.1 Human Varicella-Zoster Immunoglobulin Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Human Varicella-Zoster Immunoglobulin Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Varicella-Zoster Immunoglobulin as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Freeze-dried Powder
3.1.2 Injection
3.2 Global Human Varicella-Zoster Immunoglobulin Sales Value by Type
3.2.1 Global Human Varicella-Zoster Immunoglobulin Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Human Varicella-Zoster Immunoglobulin Sales Value, by Type (2019-2030)
3.2.3 Global Human Varicella-Zoster Immunoglobulin Sales Value, by Type (%) (2019-2030)
3.3 Global Human Varicella-Zoster Immunoglobulin Sales Volume by Type
3.3.1 Global Human Varicella-Zoster Immunoglobulin Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Human Varicella-Zoster Immunoglobulin Sales Volume, by Type (2019-2030)
3.3.3 Global Human Varicella-Zoster Immunoglobulin Sales Volume, by Type (%) (2019-2030)
3.4 Global Human Varicella-Zoster Immunoglobulin Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Human Varicella-Zoster Immunoglobulin Sales Value by Application
4.2.1 Global Human Varicella-Zoster Immunoglobulin Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Human Varicella-Zoster Immunoglobulin Sales Value, by Application (2019-2030)
4.2.3 Global Human Varicella-Zoster Immunoglobulin Sales Value, by Application (%) (2019-2030)
4.3 Global Human Varicella-Zoster Immunoglobulin Sales Volume by Application
4.3.1 Global Human Varicella-Zoster Immunoglobulin Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Human Varicella-Zoster Immunoglobulin Sales Volume, by Application (2019-2030)
4.3.3 Global Human Varicella-Zoster Immunoglobulin Sales Volume, by Application (%) (2019-2030)
4.4 Global Human Varicella-Zoster Immunoglobulin Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Human Varicella-Zoster Immunoglobulin Sales Value by Region
5.1.1 Global Human Varicella-Zoster Immunoglobulin Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Human Varicella-Zoster Immunoglobulin Sales Value by Region (2019-2024)
5.1.3 Global Human Varicella-Zoster Immunoglobulin Sales Value by Region (2025-2030)
5.1.4 Global Human Varicella-Zoster Immunoglobulin Sales Value by Region (%), (2019-2030)
5.2 Global Human Varicella-Zoster Immunoglobulin Sales Volume by Region
5.2.1 Global Human Varicella-Zoster Immunoglobulin Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Human Varicella-Zoster Immunoglobulin Sales Volume by Region (2019-2024)
5.2.3 Global Human Varicella-Zoster Immunoglobulin Sales Volume by Region (2025-2030)
5.2.4 Global Human Varicella-Zoster Immunoglobulin Sales Volume by Region (%), (2019-2030)
5.3 Global Human Varicella-Zoster Immunoglobulin Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Human Varicella-Zoster Immunoglobulin Sales Value, 2019-2030
5.4.2 North America Human Varicella-Zoster Immunoglobulin Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Human Varicella-Zoster Immunoglobulin Sales Value, 2019-2030
5.5.2 Europe Human Varicella-Zoster Immunoglobulin Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Human Varicella-Zoster Immunoglobulin Sales Value, 2019-2030
5.6.2 Asia Pacific Human Varicella-Zoster Immunoglobulin Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Human Varicella-Zoster Immunoglobulin Sales Value, 2019-2030
5.7.2 South America Human Varicella-Zoster Immunoglobulin Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Value, 2019-2030
5.8.2 Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Varicella-Zoster Immunoglobulin Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Human Varicella-Zoster Immunoglobulin Sales Value
6.2.1 Key Countries/Regions Human Varicella-Zoster Immunoglobulin Sales Value, 2019-2030
6.2.2 Key Countries/Regions Human Varicella-Zoster Immunoglobulin Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Human Varicella-Zoster Immunoglobulin Sales Value, 2019-2030
6.3.2 United States Human Varicella-Zoster Immunoglobulin Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Human Varicella-Zoster Immunoglobulin Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Human Varicella-Zoster Immunoglobulin Sales Value, 2019-2030
6.4.2 Europe Human Varicella-Zoster Immunoglobulin Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Human Varicella-Zoster Immunoglobulin Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Human Varicella-Zoster Immunoglobulin Sales Value, 2019-2030
6.5.2 China Human Varicella-Zoster Immunoglobulin Sales Value by Type (%), 2023 VS 2030
6.5.3 China Human Varicella-Zoster Immunoglobulin Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Human Varicella-Zoster Immunoglobulin Sales Value, 2019-2030
6.6.2 Japan Human Varicella-Zoster Immunoglobulin Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Human Varicella-Zoster Immunoglobulin Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Human Varicella-Zoster Immunoglobulin Sales Value, 2019-2030
6.7.2 South Korea Human Varicella-Zoster Immunoglobulin Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Human Varicella-Zoster Immunoglobulin Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Human Varicella-Zoster Immunoglobulin Sales Value, 2019-2030
6.8.2 Southeast Asia Human Varicella-Zoster Immunoglobulin Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Human Varicella-Zoster Immunoglobulin Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Human Varicella-Zoster Immunoglobulin Sales Value, 2019-2030
6.9.2 India Human Varicella-Zoster Immunoglobulin Sales Value by Type (%), 2023 VS 2030
6.9.3 India Human Varicella-Zoster Immunoglobulin Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bio Products Laboratory
7.1.1 Bio Products Laboratory Company Information
7.1.2 Bio Products Laboratory Introduction and Business Overview
7.1.3 Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Product Offerings
7.1.5 Bio Products Laboratory Recent Development
7.2 MassBiologics
7.2.1 MassBiologics Company Information
7.2.2 MassBiologics Introduction and Business Overview
7.2.3 MassBiologics Human Varicella-Zoster Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
7.2.4 MassBiologics Human Varicella-Zoster Immunoglobulin Product Offerings
7.2.5 MassBiologics Recent Development
7.3 Saol Therapeutics
7.3.1 Saol Therapeutics Company Information
7.3.2 Saol Therapeutics Introduction and Business Overview
7.3.3 Saol Therapeutics Human Varicella-Zoster Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Saol Therapeutics Human Varicella-Zoster Immunoglobulin Product Offerings
7.3.5 Saol Therapeutics Recent Development
7.4 Aptevo Biotherapeutics Llc
7.4.1 Aptevo Biotherapeutics Llc Company Information
7.4.2 Aptevo Biotherapeutics Llc Introduction and Business Overview
7.4.3 Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Product Offerings
7.4.5 Aptevo Biotherapeutics Llc Recent Development
7.5 Ki Biopharma Llc
7.5.1 Ki Biopharma Llc Company Information
7.5.2 Ki Biopharma Llc Introduction and Business Overview
7.5.3 Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Product Offerings
7.5.5 Ki Biopharma Llc Recent Development
7.6 Cangene Biopharma
7.6.1 Cangene Biopharma Company Information
7.6.2 Cangene Biopharma Introduction and Business Overview
7.6.3 Cangene Biopharma Human Varicella-Zoster Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Cangene Biopharma Human Varicella-Zoster Immunoglobulin Product Offerings
7.6.5 Cangene Biopharma Recent Development
7.7 Kamada
7.7.1 Kamada Company Information
7.7.2 Kamada Introduction and Business Overview
7.7.3 Kamada Human Varicella-Zoster Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Kamada Human Varicella-Zoster Immunoglobulin Product Offerings
7.7.5 Kamada Recent Development
7.8 Salmedon
7.8.1 Salmedon Company Information
7.8.2 Salmedon Introduction and Business Overview
7.8.3 Salmedon Human Varicella-Zoster Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Salmedon Human Varicella-Zoster Immunoglobulin Product Offerings
7.8.5 Salmedon Recent Development
8 Industry Chain Analysis
8.1 Human Varicella-Zoster Immunoglobulin Industrial Chain
8.2 Human Varicella-Zoster Immunoglobulin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human Varicella-Zoster Immunoglobulin Sales Model
8.5.2 Sales Channel
8.5.3 Human Varicella-Zoster Immunoglobulin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Human Varicella-Zoster Immunoglobulin Market Trends
Table 2. Human Varicella-Zoster Immunoglobulin Market Drivers & Opportunity
Table 3. Human Varicella-Zoster Immunoglobulin Market Challenges
Table 4. Human Varicella-Zoster Immunoglobulin Market Restraints
Table 5. Global Human Varicella-Zoster Immunoglobulin Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Human Varicella-Zoster Immunoglobulin Revenue Market Share by Company (2019-2024)
Table 7. Global Human Varicella-Zoster Immunoglobulin Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Human Varicella-Zoster Immunoglobulin Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Human Varicella-Zoster Immunoglobulin Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Human Varicella-Zoster Immunoglobulin Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Human Varicella-Zoster Immunoglobulin Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Human Varicella-Zoster Immunoglobulin
Table 13. Global Human Varicella-Zoster Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Varicella-Zoster Immunoglobulin as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Varicella-Zoster Immunoglobulin Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Human Varicella-Zoster Immunoglobulin Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Human Varicella-Zoster Immunoglobulin Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Human Varicella-Zoster Immunoglobulin Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Human Varicella-Zoster Immunoglobulin Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Human Varicella-Zoster Immunoglobulin Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Human Varicella-Zoster Immunoglobulin Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Human Varicella-Zoster Immunoglobulin Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Human Varicella-Zoster Immunoglobulin Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Human Varicella-Zoster Immunoglobulin Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Human Varicella-Zoster Immunoglobulin Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Human Varicella-Zoster Immunoglobulin Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Human Varicella-Zoster Immunoglobulin Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Human Varicella-Zoster Immunoglobulin Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Human Varicella-Zoster Immunoglobulin Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Human Varicella-Zoster Immunoglobulin Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Human Varicella-Zoster Immunoglobulin Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Human Varicella-Zoster Immunoglobulin Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Human Varicella-Zoster Immunoglobulin Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Human Varicella-Zoster Immunoglobulin Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Human Varicella-Zoster Immunoglobulin Sales Value by Region (2019-2024) & (%)
Table 44. Global Human Varicella-Zoster Immunoglobulin Sales Value by Region (2025-2030) & (%)
Table 45. Global Human Varicella-Zoster Immunoglobulin Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Human Varicella-Zoster Immunoglobulin Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Human Varicella-Zoster Immunoglobulin Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Human Varicella-Zoster Immunoglobulin Sales Volume by Region (2019-2024) & (%)
Table 49. Global Human Varicella-Zoster Immunoglobulin Sales Volume by Region (2025-2030) & (%)
Table 50. Global Human Varicella-Zoster Immunoglobulin Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Human Varicella-Zoster Immunoglobulin Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Human Varicella-Zoster Immunoglobulin Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Human Varicella-Zoster Immunoglobulin Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Human Varicella-Zoster Immunoglobulin Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Human Varicella-Zoster Immunoglobulin Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Human Varicella-Zoster Immunoglobulin Sales Volume, (2025-2030) & (K Units)
Table 57. Bio Products Laboratory Company Information
Table 58. Bio Products Laboratory Introduction and Business Overview
Table 59. Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Product Offerings
Table 61. Bio Products Laboratory Recent Development
Table 62. MassBiologics Company Information
Table 63. MassBiologics Introduction and Business Overview
Table 64. MassBiologics Human Varicella-Zoster Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. MassBiologics Human Varicella-Zoster Immunoglobulin Product Offerings
Table 66. MassBiologics Recent Development
Table 67. Saol Therapeutics Company Information
Table 68. Saol Therapeutics Introduction and Business Overview
Table 69. Saol Therapeutics Human Varicella-Zoster Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Saol Therapeutics Human Varicella-Zoster Immunoglobulin Product Offerings
Table 71. Saol Therapeutics Recent Development
Table 72. Aptevo Biotherapeutics Llc Company Information
Table 73. Aptevo Biotherapeutics Llc Introduction and Business Overview
Table 74. Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Product Offerings
Table 76. Aptevo Biotherapeutics Llc Recent Development
Table 77. Ki Biopharma Llc Company Information
Table 78. Ki Biopharma Llc Introduction and Business Overview
Table 79. Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Product Offerings
Table 81. Ki Biopharma Llc Recent Development
Table 82. Cangene Biopharma Company Information
Table 83. Cangene Biopharma Introduction and Business Overview
Table 84. Cangene Biopharma Human Varicella-Zoster Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Cangene Biopharma Human Varicella-Zoster Immunoglobulin Product Offerings
Table 86. Cangene Biopharma Recent Development
Table 87. Kamada Company Information
Table 88. Kamada Introduction and Business Overview
Table 89. Kamada Human Varicella-Zoster Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Kamada Human Varicella-Zoster Immunoglobulin Product Offerings
Table 91. Kamada Recent Development
Table 92. Salmedon Company Information
Table 93. Salmedon Introduction and Business Overview
Table 94. Salmedon Human Varicella-Zoster Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Salmedon Human Varicella-Zoster Immunoglobulin Product Offerings
Table 96. Salmedon Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Human Varicella-Zoster Immunoglobulin Downstream Customers
Table 100. Human Varicella-Zoster Immunoglobulin Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Varicella-Zoster Immunoglobulin Product Picture
Figure 2. Global Human Varicella-Zoster Immunoglobulin Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Human Varicella-Zoster Immunoglobulin Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Human Varicella-Zoster Immunoglobulin Sales Volume (2019-2030) & (K Units)
Figure 5. Global Human Varicella-Zoster Immunoglobulin Sales Price (2019-2030) & (US$/Unit)
Figure 6. Human Varicella-Zoster Immunoglobulin Report Years Considered
Figure 7. Global Human Varicella-Zoster Immunoglobulin Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Human Varicella-Zoster Immunoglobulin Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Varicella-Zoster Immunoglobulin Revenue in 2023
Figure 10. Human Varicella-Zoster Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Freeze-dried Powder Picture
Figure 12. Injection Picture
Figure 13. Global Human Varicella-Zoster Immunoglobulin Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Human Varicella-Zoster Immunoglobulin Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Human Varicella-Zoster Immunoglobulin Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Human Varicella-Zoster Immunoglobulin Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Human Varicella-Zoster Immunoglobulin Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Clinic
Figure 20. Global Human Varicella-Zoster Immunoglobulin Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Human Varicella-Zoster Immunoglobulin Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Human Varicella-Zoster Immunoglobulin Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 23. Global Human Varicella-Zoster Immunoglobulin Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Human Varicella-Zoster Immunoglobulin Price by Application (2019-2030) & (US$/Unit)
Figure 25. North America Human Varicella-Zoster Immunoglobulin Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Human Varicella-Zoster Immunoglobulin Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Human Varicella-Zoster Immunoglobulin Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Human Varicella-Zoster Immunoglobulin Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Human Varicella-Zoster Immunoglobulin Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Human Varicella-Zoster Immunoglobulin Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Human Varicella-Zoster Immunoglobulin Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Human Varicella-Zoster Immunoglobulin Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Human Varicella-Zoster Immunoglobulin Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Human Varicella-Zoster Immunoglobulin Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Human Varicella-Zoster Immunoglobulin Sales Volume (%), (2019-2030)
Figure 37. United States Human Varicella-Zoster Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Human Varicella-Zoster Immunoglobulin Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Human Varicella-Zoster Immunoglobulin Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Human Varicella-Zoster Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Human Varicella-Zoster Immunoglobulin Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Human Varicella-Zoster Immunoglobulin Sales Value by Application (%), 2023 VS 2030
Figure 43. China Human Varicella-Zoster Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Human Varicella-Zoster Immunoglobulin Sales Value by Type (%), 2023 VS 2030
Figure 45. China Human Varicella-Zoster Immunoglobulin Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Human Varicella-Zoster Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Human Varicella-Zoster Immunoglobulin Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Human Varicella-Zoster Immunoglobulin Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Human Varicella-Zoster Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Human Varicella-Zoster Immunoglobulin Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Human Varicella-Zoster Immunoglobulin Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Human Varicella-Zoster Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Human Varicella-Zoster Immunoglobulin Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Human Varicella-Zoster Immunoglobulin Sales Value by Application (%), 2023 VS 2030
Figure 55. India Human Varicella-Zoster Immunoglobulin Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Human Varicella-Zoster Immunoglobulin Sales Value by Type (%), 2023 VS 2030
Figure 57. India Human Varicella-Zoster Immunoglobulin Sales Value by Application (%), 2023 VS 2030
Figure 58. Human Varicella-Zoster Immunoglobulin Industrial Chain
Figure 59. Human Varicella-Zoster Immunoglobulin Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
